central bank decisions, rates, inflation and data releases, explained through their market impact.
stories appear here with a 15-minute delay. in real time — via the api connect the api →
1662 stories · page 49 / 84
Average 12-month targets for HSBC Holdings and Chagee Holdings increased. The consensus is “Hold” for HSBC and “Buy” for Chagee.
5 sources · Newsmetry API, TradingView
Citizens reduced its AMERISAFE price target to $40 per share from $42 while maintaining a Market Outperform rating, Dow Jones Newswires reports.
1 source · Dow Jones Newswires
Analysts lifted average 12-month targets for both companies. The implied upside is about 16% for Cincinnati Financial and 9% for Adaptive Biotechnologies.
2 sources · Newsmetry API, TradingView
TradingView and Newsmetry API reported changes to 12-month price targets for six companies, while consensus ratings largely remained unchanged.
11 sources · Newsmetry API, TradingView
Guggenheim kept Buy ratings on Elevance Health at $460 and Everpure at $215, citing earnings growth, market share gains and improving margins.
2 sources · TradingView
Citigroup reduced its Blackstone Digital Infra price target from $23.00 to $20.00 per share, according to Benzinga’s analyst-actions report.
1 source · Dow Jones Newswires
Asiasec Properties proposed combining 10 existing shares into one and issuing 124.1 million rights shares to raise up to HK$151.36 million.
1 source · Reuters
Bank of India classified Future Enterprises’ ₹575.40 crore NPA account as fraud and reported it to the RBI. The lender has fully provisioned the exposure.
2 sources · CNBC TV18, Newsmetry API
Berenberg lowered SSP’s target to 225p after Q4, citing a 4% FY26 EBIT miss, weaker US trends and free cash flow of around £70m.
1 source · ShareCast
BlackRock, T. Rowe Price, UBS and other funds disclosed Prologis positions and trades under the Takeover Code, also naming SEGRO.
9 sources · London Stock Exchange, Newsmetry API
Keefe, Bruyette & Woods maintained its Underperform rating on Allstate and cut the insurer’s price target to $232 a share from $250.
1 source · Dow Jones Newswires
Leerink Partners kept its Outperform rating and $112 target for CVS Health, implying 30.0% upside from the stock’s Oct. 9 close at $86.16.
1 source · TradingView
Bank of America analyst Tal Liani says AI disruption risks have eased for Salesforce and raises the stock rating to Buy with a $285 target.
1 source · Dow Jones Newswires
AST SpaceMobile shares are down over 60% from their record high, but Deutsche Bank raised its rating to Buy and kept a $93 target.
1 source · Stocktwits
Goldman Sachs raised its three-month view on global equities to overweight, citing supportive earnings growth and more attractive valuations before results.
1 source · Reuters
Raymond James disclosed a 1.16% Eleco PLC stake after selling 24,980 shares, while Crédit Mutuel reported 2.69% after buying 87,500 shares.
2 sources · London Stock Exchange, Newsmetry API
StoneX retained its Buy rating on Securitize Holdings and an $18 target, implying 30.2% upside from the stock’s Oct. 9 close of $13.82.
1 source · TradingView
Xponential Fitness approved a 19.9% rights-plan trigger after a significant equity accumulation. The measure is effective immediately and expires October 11, 2027.
2 sources · BusinessWire, TradingView
AI-linked shares face demanding profit expectations as mixed headlines and vast infrastructure costs raise fresh questions about the rally’s durability.
1 source · Reuters
Raymond James called concerns about SpaceX competition overstated and upgraded T-Mobile from Market Perform to Outperform, citing network advantages.
1 source · Dow Jones Newswires